A Phase II, Randomized, Multicenter Study Evaluating the Combination of Lapatinib and Vinorelbine in Women With ErbB2 Overexpressing Metastatic Breast Cancer

Breast Cancer Research and Treatment - Netherlands
doi 10.1007/s10549-013-2828-z

Related search